Back to search

Article

<i>In vivo</i> CRISPR screens reveal SCAF1 and USP15 as novel drivers of pancreatic cancer

2022-03-13

Abstract excerpt

Functionally characterizing the genetic alterations that drive pancreatic cancer progression is a prerequisite for Precision Medicine. Here, we developed a somatic CRISPR/Cas9 mutagenesis screen to assess the transforming potential of 125 recurrently mutated ‘long-tail’ pancreatic cancer genes, which revealed USP15 and SCAF1 as novel and potent Pancreatic ductal adenocarcinoma PDAC tumor suppressors, with USP15 fu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c14ece73-3e2e-5118-9b52-f8c40f98795f
DOI
10.1101/2022.03.13.484174
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>In vivo</i> CRISPR screens reveal SCAF1 and USP15 as novel drivers of pancreatic cancerDOI 10.1101/2022.03.13.484174
Select a neighboring publication to make it the new centre.